FDA NDA 018932, REVIA, TEVA WOMENS, 11/20/1984

Contents: Summary Basis of Approval of NALTREXONE HYDROCHLORIDE (REVIA) TABLET    ORAL 50MG for the Applicant TEVA WOMENS HEALTH INC

NDA: 018932
Company: TEVA WOMENS
Drug Name: REVIA
Active Ingredients: NALTREXONE HYDROCHLORIDE
Strength: 50MG
Dosage Form/Route: TABLET;ORAL
Action Date: 11/20/1984
Marketing Status: Discontinued
Submission Classification: ORIG-1
Action Date: None

601 Pages